The pharmacological treatment of obesity is a fast-changing landscape, and care providers must strive continuously to stay current. Before 2012, there were few weight loss medications approved by the FDA. The top anti-obesity medications (AOMs) at that time were phentermine, marketed as Lomaira and Adipex-P, and orlistat, marketed as Xenical and Alli .
So, many weight loss medications are available in the pharmacy markets. But people should be used to the health care expert’s advice. Using the wrong products will cause side effects in the body. Following natural methods also provides good results, but it will take time to get good results.
The landscape of obesity treatment is definitely evolving fast, especially compared to the limited options before 2012 like phentermine and orlistat. Thanks for sharing this update—staying current really matters for proper care. If you got any charts or notes you want to exchange don’t forget to share with us.